SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease

详细信息    查看全文

• 作者：Jiyung Shin ; Ming He ; Yufei Liu ; Silvana Paredes ; Lidia Villanova ; Katharine Brown ; Xiaolei Qiu ; Noushin Nabavi ; Mary Mohrin ; Kathleen Wojnoonski ; Patrick Li ; Hwei-Ling Cheng ; Andrew聽J. Murphy ; David聽M. Valenzuela ; Hanzhi Luo ; Pankaj Kapahi ; Ronald Krauss ; Raul Mostoslavsky ; George聽D. Yancopoulos ; Frederick聽W. Alt ; et al.
• 刊名：Cell Reports
• 出版年：14 November, 2013
• 年：2013
• 卷：5
• 期：3
• 页码：654-665
• 全文大小：3259 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Nonalcoholic fatty liver disease is the most common chronic liver disorder in developed countries. Its pathogenesis is poorly understood, and therapeutic options are limited. Here, we show that SIRT7, an NAD⁺-dependent H3K18Ac deacetylase, functions at chromatin to suppress ER stress and prevent the development of fatty liver disease. SIRT7 is induced upon ER stress and is stabilized at the promoters of ribosomal proteins through its聽interaction with the transcription factor Myc to silence gene expression and to relieve ER stress. SIRT7-deficient mice develop chronic hepatosteatosis resembling human fatty liver disease. Myc inactivation or pharmacological suppression of ER stress alleviates fatty liver caused by SIRT7 deficiency. Importantly, SIRT7 suppresses ER stress and reverts the fatty liver disease in diet-induced obese mice. Our study identifies SIRT7 as a cofactor of Myc for transcriptional repression and delineates a druggable regulatory branch of the ER stress response that prevents and reverts fatty liver disease.